Xencor (XNCR) Consolidated Net Income (2013 - 2026)

Xencor's (XNCR) quarterly Consolidated Net Income came in at -$128.9 million in Q1 2026, down 164.95% year-on-year from $198.5 million in Q1 2025, and down 1838.01% on a QoQ basis from -$6.7 million in Q4 2025.

Xencor (XNCR) Consolidated Net Income (2013 - 2026) Analysis & Trends

Xencor (XNCR) has 14 years of Consolidated Net Income data on file, last reported at -$128.9 million in Q1 2026.

  • On a quarterly basis, Consolidated Net Income fell 164.95% year-over-year to -$128.9 million in Q1 2026; TTM through Mar 2026 was -$172.4 million, a 18.31% increase from a year earlier, with the FY2025 full-year figure at -$92.1 million, up 61.05% from the prior year.
  • Consolidated Net Income for Q1 2026 stood at -$128.9 million, down from -$6.7 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for XNCR reached as high as $25.8 million in Q1 2022 and fell as low as -$128.9 million in Q1 2026.
  • Historically, Consolidated Net Income has averaged -$42.2 million across 5 years, with a median of -$46.2 million in 2024.
  • Across the five-year window, Consolidated Net Income surged 259.43% in 2022 and plunged 327.17% in 2023, its largest moves.
  • Year by year, Consolidated Net Income stood at -$12.0 million in 2022, then sank by 118.49% to -$26.3 million in 2023, then sank by 75.6% to -$46.2 million in 2024, then surged by 85.6% to -$6.7 million in 2025, then plunged by 1838.01% to -$128.9 million in 2026.
  • Per Business Quant data, the three most recent Consolidated Net Income figures were -$128.9 million in Q1 2026, -$6.7 million in Q4 2025, and -$6.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 67,042.03 Bn 67,041.74 Bn - -37.09 Mn
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - -
3 Akari Therapeutics 989.71 Bn 989.71 Bn - -14.46 Mn
4 BeOne Medicines 471.62 Bn 466.83 Bn 1.35 Bn 227.36 Mn
5 Vertex Pharmaceuticals 121.97 Bn 114.72 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 69.98 Bn 61.22 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 62.68 Bn 62.68 Bn - -26.94 Mn
8 Argenx Se 55.75 Bn 50.57 Bn 1.41 Bn 362.00 Mn
9 Alnylam Pharmaceuticals 37.49 Bn 34.48 Bn 959.66 Mn 205.99 Mn
10 Xencor 1.51 Bn 1.13 Bn - -128.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -128.94 Mn
Dec 31, 2025 -6.65 Mn
Sep 30, 2025 -6.03 Mn
Jun 30, 2025 -30.83 Mn
Mar 31, 2025 -48.67 Mn
Dec 31, 2024 -46.20 Mn
Sep 30, 2024 -47.44 Mn
Jun 30, 2024 -68.78 Mn
Mar 31, 2024 -74.12 Mn
Dec 31, 2023 -26.31 Mn
Sep 30, 2023 -24.27 Mn
Jun 30, 2023 -71.11 Mn
Mar 31, 2023 -58.57 Mn
Dec 31, 2022 -12.04 Mn
Sep 30, 2022 -32.76 Mn
Jun 30, 2022 -60.59 Mn
Mar 31, 2022 25.78 Mn
Dec 31, 2021 73.06 Mn
Sep 30, 2021 -40.19 Mn
Jun 30, 2021 -56.30 Mn